Pharma-Bio Serv (PBSV) News Today → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free PBSV Stock Alerts $0.75 +0.01 (+2.03%) (As of 05/3/2024 11:45 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartDividendEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartDividendEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePharma-Bio Serv (OTCMKTS:PBSV) Share Price Passes Below Two Hundred Day Moving Average of $0.91americanbankingnews.com - May 4 at 4:42 AMBBIO Stock Earnings: BridgeBio Pharma Beats EPS, Beats Revenue for Q1 2024markets.businessinsider.com - May 2 at 11:37 PMPharma-Bio Serv (OTCMKTS:PBSV) Stock Passes Below Two Hundred Day Moving Average of $0.91americanbankingnews.com - April 26 at 4:02 AMDeep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (8 Ratings)markets.businessinsider.com - April 25 at 4:06 PMEQS-News: Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratóriosmarkets.businessinsider.com - April 25 at 5:40 AMBiomarin Pharmaceutical earnings preview: what Wall Street is expectingmarkets.businessinsider.com - April 23 at 10:14 AMBuy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Sales Outlook and Optimized Market Expectationsmarkets.businessinsider.com - April 16 at 3:38 AMSanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i®, Scientist.com's Supplier Pre-assessment Programtmcnet.com - April 9 at 8:56 AMLooking Into Biomarin Pharmaceutical's Recent Short Interestbenzinga.com - April 3 at 3:20 PMPBSV Releases Quarterly Resultsfinance.yahoo.com - March 19 at 3:02 PMPharma-Bio Serv reports Q1 resultsseekingalpha.com - March 19 at 10:01 AMBuy Rating Affirmed for BridgeBio Pharma Amidst Strategic Bayer Collaboration and Promising Financial Outlookmarkets.businessinsider.com - March 4 at 11:00 PMMaintaining Hold on BridgeBio Pharma Amidst Bayer Partnership and Market Uncertaintiesmarkets.businessinsider.com - March 4 at 12:58 PMBioMarin Pharmaceutical Gets DOJ Subpoena for Documents Related to Vimizim, Naglazyme -- Updatemarketwatch.com - February 26 at 4:21 PMStrong Voxzogo Performance Underpins Buy Rating for BioMarin Pharmaceuticalmarkets.businessinsider.com - February 23 at 8:53 PMPBSV Expands Margins and Marketsfinance.yahoo.com - January 30 at 4:38 PMJubilant Pharma Plans Stake Sale in Sofie Biosciences Amid Merger Dealmsn.com - January 28 at 10:10 AMOptimistic Outlook: Buy Rating for BridgeBio Pharma with Promising Treatment Launches and Strategic Growth Driversmarkets.businessinsider.com - January 9 at 8:52 PMBridgeBio Pharma's Robust Pipeline Could Benefit From A Partnerseekingalpha.com - January 8 at 8:02 AMPBSV Reward Shareholders with High Yieldfinance.yahoo.com - January 3 at 3:22 PMPharma-Bio Serv Inc.: Pharma-Bio Serv Announces Special Dividendfinanznachrichten.de - December 21 at 1:54 PMAbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?msn.com - December 8 at 8:18 AMBioMarin Pharma Reaches Agreement On Reimbursement Amount For ROCTAVIAN In Germanymarkets.businessinsider.com - November 28 at 9:18 AMPromising Future for BridgeBio Pharma: Lebovitz’s Buy Rating Backed by Potential Blockbusters and Pipeline Assetsmarkets.businessinsider.com - November 7 at 9:45 PMBridgeBio Pharma Receives Buy Rating Amid Promising Drug Pipeline Developments and Strong Financial Positionmarkets.businessinsider.com - November 6 at 11:56 PMPBSV Boosts Margins and Expands Marketsfinance.yahoo.com - September 15 at 2:16 PMPharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023finance.yahoo.com - September 14 at 7:03 PMAnalysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (BMRN) and Phibro Animal Health (PAHC)markets.businessinsider.com - August 31 at 9:00 AMPharma-Bio Serv Incthestreet.com - July 28 at 9:44 AMBridgeBio Pharma: Positive ATTR-CM Treatment Data Leads To Other 2023 Catalystsmsn.com - July 17 at 9:06 PMBridgeBio Pharma Shares Rise 14% on Expected Results from Heart-Disease Studymarketwatch.com - July 15 at 12:01 AMStocks to Watch: BridgeBio Pharma, Universal Security Instruments, BYND Cannasoft Enterprisesmarketwatch.com - July 15 at 12:01 AMPearl Bio Secures Breakthrough IP for Multi-Functionalized Biologicstechnews.tmcnet.com - June 20 at 10:02 AMPBSV: A Consistent Performer with Impressive Dividendfinance.yahoo.com - June 15 at 2:00 PMPharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2023finance.yahoo.com - June 14 at 6:53 PMTBPMF - Tetra Bio-Pharma Inc.ca.finance.yahoo.com - June 13 at 3:56 PMPBSV - Pharma-Bio Serv, Inc.finance.yahoo.com - June 10 at 12:10 PMAvid Bioservices Bolsters Manufacturing Capabilities And Generates High-Demand Servicesmsn.com - May 20 at 3:40 AMBridgeBio Pharma to Present Updated Data from itstmcnet.com - May 15 at 10:22 AMBio Pharma Buffer Market Research | 2023-2030marketwatch.com - May 10 at 3:56 AMGlobal "Bio Pharma Logistics Market" 2023 Research Report | Enhanced Growth Size, Estimates and Regional Outlook by 2030 | Research Reports Worldmarketwatch.com - May 9 at 7:52 AMHere's what Wall Street expects from Biomarin Pharmaceutical's earningsmarkets.businessinsider.com - April 25 at 11:28 AMPharma-Bio Serv Stock (OTC:PBSV), Quotes and News Summarybenzinga.com - April 20 at 9:06 PMBio Pharma Buffer Market 2023 Size and Forecast to 2031marketwatch.com - April 8 at 11:29 PMPBSV: A Steady Performer with Upside Potentialfinance.yahoo.com - March 20 at 3:51 PMPharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023finance.yahoo.com - March 17 at 8:07 PM4 Analysts Have This to Say About BridgeBio Pharmamarkets.businessinsider.com - March 7 at 10:54 AMSVB Securities Keeps Their Buy Rating on BioMarin Pharmaceutical (BMRN)markets.businessinsider.com - March 3 at 1:08 AMBio Pharma Buffer Market 2023: Emerging Trends and Best Practices in Futurism till 2028marketwatch.com - February 21 at 8:14 AMBio Pharma Logistics Market Growth, Business Overview and Forecast to 2028marketwatch.com - February 16 at 8:02 PM Get Pharma-Bio Serv News Delivered to You Automatically Sign up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter. Email Address Gold Mania (Ad)Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite). See his free reveal right here. PBSV Media Mentions By Week PBSV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PBSV News Sentiment▼0.450.40▲Average Business Services News Sentiment PBSV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PBSV Articles This Week▼20▲PBSV Articles Average Week Get Pharma-Bio Serv News Delivered to You Automatically Sign up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CTM News Today GOPH News Today ATIF News Today RVYL News Today AERT News Today DHAI News Today SGLY News Today ATER News Today PRST News Today ZPTA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PBSV) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma-Bio Serv, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
